Pharmafile Logo
Pharmafocus logo
Advanced Search

Reinventing the value equation

April 27, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Drug pricing, feature, real world data, real world evidence, real-world data, real-world evidence

There is a duty to ensure access to innovative treatments for patients with unmet need, but a health service gatekeeper …

Feature

Sanofi’s Meningococcal Conjugate Vaccine secures FDA approval in patients aged two and up

April 27, 2020
Sales and Marketing FDA, MenQuadfi, Sanofi, US, meningococcal disease, pharma

Sanofi’s MedQuadfi Meningococcal Conjugate Vaccine has scored FDA approval for the prevention of invasive meningococcal disease, becoming the first and …

News
italy_lockdown

Italy to relax COVID-19 lockdown in early May

April 27, 2020
Sales and Marketing COVID-19, COVID-19 coronavirus, Italy, coronavirus

Italy has outlined its plans to ease the lockdown restrictions that were implemented across the country 7 weeks ago to …

News
researchers

Researchers studying heartburn drug as potential coronavirus treatment

April 27, 2020
Sales and Marketing COVID-19, Pepcid, coronavirus, pandemic

Researchers in America have been studying famotidine, the active ingredient in Pepcid, as a potential treatment for COVID-19. Pepcid is …

News
hazmat

‘Excess deaths’ in England among the highest in Europe

April 27, 2020
Sales and Marketing COVID-19, coronavirus, deaths, pandemic

English excess deaths from the coronavirus are comparable to the worst hit countries in Europe, according to a Sky News …

News
images_1

FDA urges close monitoring of COVID-19 patients treated with hydroxychloroquine

April 27, 2020
Sales and Marketing COVID-19, FDA, chloroquine, coronavirus, hydroxychloroquine

The FDA has released a safety communication reiterating the need for doctors to closely monitor COVID-19 patients who are treated …

News
aloe-vera-2417091_960_720

European Medicines Agency’s review of Picato finds its risks outweigh its benefits

April 24, 2020
Business Services, Medical Communications, Sales and Marketing

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has confirmed that the risks from using Picato are too high …

News
gilead-sciences

Leading COVID-19 hope remdesivir fails to provide clinical benefit in first randomised trial

April 24, 2020
Medical Communications, Research and Development COVID-19, Gilead, coronavirus, pharma, remdesivir

Gilead’s remdesivir, which has been hailed as one of the few truly promising treatments for COVID-19 at this early stage …

News
top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

April 24, 2020
Medical Communications COVID-19, coronavirus, top 10

Hydroxychloroquine is once again a main feature in the news as it fails a coronavirus clinical trial in France, while …

News
wuhan

European countries wary about confronting China over COVID-19 death figures

April 24, 2020
Medical Communications COVID-19, China, coronavirus

National security experts in the UK and US believe China is underreporting the true amount of COVID-19 deaths, but European …

News
new_trump

Trump widely criticised for suggesting patients could receive injections of disinfectant as COVID-19 cure

April 24, 2020
Medical Communications COVID-19, coronavirus

President Donald Trump stunned the medical community by suggesting disinfectant and UV light could be used to treat patients suffering …

News
social_distancing

Socially disruptive measures will exist in Britain until at least the end of the year

April 23, 2020
Business Services Britian COVID-19, COVID-19, coronavirus

England’s Chief Medical Officer Chris Whitty has said that the UK will have to live with some form of socially …

News

FDA approves Immunomedics’ Trodelvy for metastatic triple-negative breast cancer one month ahead of schedule

April 23, 2020
Sales and Marketing Cancer, Immunomedics, Trodelvy, breast cancer, pharma

Immunomedics has scored approval with the FDA for Trodelvy (sacituzumab govitecan-hziy) in the treatment of metastatic triple-negative breast cancer, it …

News
fda

Cheaper Canadian drug imports continue to be seized by the FDA

April 23, 2020
Business Services COVID-19, Canada, FDA, coronavirus, insulin

Seizures of Canadian drugs being sent to American patients have been stepped up by the FDA. This is according to …

News

Novartis’ Jakavi Phase 3 trial is first of its kind to hit main goal in steroid-refractory acute graft-versus-host disease

April 23, 2020
Research and Development Jakavi, Novartis, pharrma

Novartis has revealed impactful new Phase 3 data for its therapy Jakavi (ruxolitinib) in the treatment of patients with steroid-refractory …

News
department_of_health__human_services_-_stierch

BARDA director abruptly leaves post, claims he was ousted over pushback to hydroxychloroquine

April 23, 2020
Business Services COVID-19, HHS, coronavirus

Rick Bright has claimed that he has been forced out of his position as the Director of the US Biomedical …

News
boehringer_biberach_germany_copy

Boehringer’s nintedanib approved in Europe for systemic sclerosis-associated interstitial lung disease

April 22, 2020
Research and Development, Sales and Marketing Boehringer Ingelheim, EU, nintedanib, pharma

The European Commission has moved to authorise Boehringer Ingelheim’s nintedanib in Europe for the treatment of systemic sclerosis-associated interstitial lung …

News
coroanrvisu_cdc

Pharmafile.com’s weekly COVID-19 news round-up

April 22, 2020
Research and Development COVID-19, coronavirus, hydroxychloroquine

Hydroxychloroquine has faced setbacks as a potential COVID-19 treatment, as it failed a clinical trial in France and a study …

News
testing_kit

First in-home COVID-19 testing kit approved by the FDA

April 22, 2020
Research and Development COVID-19, Testing kits, coronavirus, testing swabs

The US Food and Drug Administration have granted emergency clearance to the first in-home COVID-19 testing kit. The nasal swab …

News
abbvie_0

AbbVie’s Imbruvica scoops up 11th FDA approval with chronic lymphocytic leukaemia/small lymphocytic lymphoma nod

April 22, 2020
Research and Development, Sales and Marketing Cancer, FDA, imbruvica, leukaemia

AbbVie’s Imbruvica (ibrutinib) has scored its 11th FDA approval, this time in combination with rituximab for the treatment of chronic …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025